Novel prognostic tissue markers in congestive heart failure

Cardiovascular Pathology

Volumn 24, Issue 2, 2015, Pages 65-70

  Stone, James R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Cyclophilin A; Gremlin 1; Heterogeneous nuclear ribonucleoprotein C; Proliferation; Ubiquitin

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYCLOPHILIN A; FORMALDEHYDE; GREMLIN 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; PARAFFIN; UBIQUITIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

CARDIOMYOPATHY; CELL DEATH; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; HEALTH CARE UTILIZATION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART SURGERY; HUMAN; IMMUNOHISTOCHEMISTRY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; HEART FAILURE;

BIOMARKERS; HEART FAILURE; HUMANS; PROGNOSIS;

EID: 84923352555     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2014.07.010     Document Type: Review

References (55)

1. AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, and WB Borden Heart disease and stroke statistics: 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
2. DS Lee, and JA Ezekowitz Risk stratification in acute heart failure Can J Cardiol 30 2014 312 319
3. SR Motiwala, and JL Januzzi Using biomarkers to «guide» heart failure management: current perspectives and future directions Cardiol Rev 21 2013 127 134
4. AP Kalogeropoulos, VV Georgiopoulou, and J Butler Clinical adoption of prognostic biomarkers: the case for heart failure Prog Cardiovasc Dis 55 2012 3 13
5. E Koutalas, E Kanoupakis, and P Vardas Sudden cardiac death in non-ischemic dilated cardiomyopathy: a critical appraisal of existing and potential risk stratification tools Int J Cardiol 167 2013 335 341
6. B Greenberg Acute decompensated heart failure - treatments and challenges Circ J 76 2012 532 543
7. O Leone, JP Veinot, A Angelini, UT Baandrup, C Basso, and G Berry Consensus statement on endomyocardial biopsy from the European Association for Cardiovascular Pathology and the Society for Cardiovascular Pathology 2011 Cardiovasc Pathol 21 2012 245 274
8. JR Stone, C Basso, UT Baandrup, P Bruneval, J Butany, and PJ Gallagher Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology Cardiovasc Pathol 21 2012 2 16
9. JR Stone Diagnostic biopsies of the native heart GL Winters, Current concepts in cardiovascular pathology, surgical pathology clinics, Saunders 2012 Saunders 401 416
10. JW Magnani, HJ Danik, GW Dec, and TG DiSalvo Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors Am Heart J 151 2006 463 470
11. GM Felker, RE Thompson, JM Hare, RH Hruban, DE Clemetson, and DL Howard Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
12. BB Das Role of endomyocardial biopsy for children presenting with acute systolic heart failure Pediatr Cardiol 35 2014 191 196
13. AL Caforio, S Pankuweit, E Arbustini, C Basso, J Gimeno-Blanes, and SB Felix Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 2636 2648
14. EK Shirey, WL Proudfit, and WA Hawk Primary myocardial disease. Correlation with clinical findings, angiographic and biopsy diagnosis. Follow-up of 139 patients Am Heart J 99 1980 198 207
15. HR Figulla, G Rahlf, M Nieger, H Luig, and H Kreuzer Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy Circulation 71 1985 1095 1104
16. F Pelliccia, G d'Amati, C Cianfrocca, P Bernucci, A Nigri, and B Marino Histomorphometric features predict 1-year outcome of patients with idiopathic dilated cardiomyopathy considered to be at low priority for cardiac transplantation Am Heart J 128 1994 316 325
17. NA Stolf, LF Moreira, EA Bocchi, ML Higuchi, F Bacal, and G Bellotti Determinants of midterm outcome of partial left ventriculectomy in dilated cardiomyopathy Ann Thorac Surg 66 1998 1585 1591
18. ML Higuchi, LF Moreira, JM Silvestre, PS Gutierrez, C Savalli, and N Stolf Myocardial fiber diameter as a good indicator of outcome in Batista's operation J Card Surg 14 1999 401 407
19. KA Soderlund, RR Chivukula, SD Russell, JV Conte, JO Mudd, and MK Halushka Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement Cardiovasc Pathol 18 2009 217 222
20. AM Segura, OH Frazier, Z Demirozu, and LM Buja Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device Cardiovasc Pathol 20 2011 139 145
21. SJ Parson, SD Russell, MK Bennett, JM Dunn, NA Gilotra, and S Rao Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults Cardiovasc Pathol 21 2012 317 323
22. DV Unverferth, RD Magorien, ML Moeschberger, PB Baker, JK Fetters, and CV Leier Factors influencing the one-year mortality of dilated cardiomyopathy Am J Cardiol 54 1984 147 152
23. F Schwarz, G Mall, H Zebe, E Schmitzer, J Manthey, and H Scheurlen Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics Circulation 70 1984 923 928
24. W Grimm, S Rudolph, M Christ, S Pankuweit, and B Maisch Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy Am Heart J 146 2003 372 376
25. LA Benvenuti, HF Freitas, AJ Mansur, and ML Higuchi Myocyte diameter and fractional area of collagen are not associated with survival time of outpatients with idiopathic dilated cardiomyopathy: a study based on right ventricular endomyocardial biopsies Int J Cardiol 116 2007 279 280
26. M Metzger, ML Higuchi, LF Moreira, MJ Chaves, JB Castelli, and JM Silvestre Relevance of apoptosis and cell proliferation for survival of patients with dilated cardiomyopathy undergoing partial left ventriculectomy Eur J Clin Invest 32 2002 394 399
27. M Zorc, O Vraspir-Porenta, R Zorc-Pleskovic, N Radovanovic, and D Petrovic Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy Cardiovasc Pathol 12 2003 36 39
28. CA Vigliano, PM Cabeza Meckert, M Diez, LE Favaloro, C Cortes, and L Fazzi Cardiomyocyte hypertrophy, oncosis, and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure J Am Coll Cardiol 57 2011 1523 1531
29. DR Hsu, AN Economides, X Wang, PM Eimon, and RM Harland The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities Mol Cell 1 1998 673 683
30. LZ Topol, B Bardot, Q Zhang, J Resau, E Huillard, and M Marx Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin J Biol Chem 275 2000 8785 8793
31. W Boers, S Aarrass, C Linthorst, M Pinzani, RO Elferink, and P Bosma Transcriptional profiling reveals novel markers of liver fibrogenesis: Gremlin and insulin-like growth factor-binding proteins J Biol Chem 281 2006 16289 16295
32. SA Roxburgh, M Murphy, CA Pollock, and DP Brazil Recapitulation of embryological programmes in renal fibrosis - the importance of epithelial cell plasticity and developmental genes Nephron Physiol 103 2006 139 148
33. S Mezzano, A Droguett, ME Burgos, C Aros, L Ardiles, and C Flores Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis Nephrol Dial Transplant 22 2007 1882 1890
34. K Koli, M Myllarniemi, K Vuorinen, K Salmenkivi, MJ Ryynanen, and VL Kinnula Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis Am J Pathol 169 2006 61 71
35. KA Mueller, E Tavlaki, M Schneider, R Jorbenadze, T Geisler, and R Kandolf Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failure undergoing endomyocardial biopsy J Card Fail 19 2013 678 684
36. P Wang, and J Heitman The cyclophilins Genome Biol 6 2005 226
37. RE Handschumacher, MW Harding, J Rice, RJ Drugge, and DW Speicher Cyclophilin: a specific cytosolic binding protein for cyclosporin A Science 226 1984 544 547
38. P Seizer, T Geisler, B Bigalke, M Schneider, K Klingel, and R Kandolf EMMPRIN and its ligand cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy Int J Cardiol 163 2013 299 304
39. CS Zuern, KA Muller, P Seizer, T Geisler, W Banya, and K Klingel Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy Eur J Heart Fail 15 2013 176 184
40. I Kindermann, M Kindermann, R Kandolf, K Klingel, B Bultmann, and T Muller Predictors of outcome in patients with suspected myocarditis Circulation 118 2008 639 648
41. A McCloskey, I Taniguchi, K Shinmyozu, and M Ohno hnRNP-C tetramer measures RNA length to classify RNA polymerase II transcripts for export Science 335 2012 1643 1646
42. O Sella, G Gerlitz, S-Y Le, and O Elroy-Stein Differentiation-induced internal translation of c-sis mRNA: analysis of the cis elements and their differentiation-linked binding to the hnRNP-C protein Mol Cell Biol 19 1999 5429 5440
43. JH Kim, KY Paek, K Choi, TD Kim, B Hahm, and KT Kim Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner Mol Cell Biol 23 2003 708 720
44. M Holcik, BW Gordon, and RG Korneluk The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2 Mol Cell Biol 23 2003 280 288
45. JR Stone, and T Collins Rapid phosphorylation of heterogeneous nuclear ribonucleoprotein C1/C2 in response to physiologic levels of hydrogen peroxide in human endothelial cells J Biol Chem 277 2002 15621 15628
46. T Kattapuram, S Yang, JL Maki, and JR Stone Protein kinase CK1α regulates mRNA binding by heterogeneous nuclear ribonucleoprotein C in response to physiologic levels of hydrogen peroxide J Biol Chem 280 2005 15340 15347
47. H Kamma, DS Portman, and G Dreyfuss Cell type-specific expression of hnRNP proteins Exp Cell Res 221 1995 187 196
48. phox Cardiovasc Pathol 23 2014 35 42
49. MP Panchenko, N Silva, and JR Stone Up-regulation of a hydrogen peroxide-responsive pre-mRNA binding protein in atherosclerosis and intimal hyperplasia Cardiovasc Pathol 18 2009 167 172
50. MP Panchenko, Z Siddiquee, DM Dombkowski, YO Alekseyev, ME Lenburg, and JD Walker Protein kinase CK1αLS promotes vascular cell proliferation and intimal hyperplasia Am J Pathol 177 2010 1562 1572
51. KA Parks, MJ Semigran, and JR Stone Myocardial upregulation of hnRNP-C predicts short term recovery in patients with acute systolic heart failure J Card Fail 15 2009 S41
52. P Sharma, J Cosme, and AO Gramolini Recent advances in cardiovascular proteomics J Proteomics 81 2013 3 14
53. M Brioschi, G Polvani, P Fratto, A Parolari, P Agostoni, and E Tremoli Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure: implications for protein function PLoS One 7 2012 e35841
54. E Hammer, M Goritzka, S Ameling, K Darm, L Steil, and K Klingel Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies J Proteome Res 10 2011 2161 2171
55. E Rosello-Lleti, J Alonso, R Cortes, L Almenar, L Martinez-Dolz, and I Sanchez-Lazaro Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue J Cell Mol Med 16 2012 2471 2486